Feds Reverse Course On Alzheimer’s Drug After Outcry From Down Syndrome Advocates
Imported
Federal officials are backing off a plan that would have kept people with Down syndrome from accessing a new Alzheimer’s treatment even though they’re predisposed to the disease.
The post Feds Reverse Course On Alzheimer’s Drug After Outcry From Down Syndrome Advocates appeared first on Disability Scoop.